Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Tuesday, December 8 2009 1:56am ET - U.S. Markets open in 7 hours and 34 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > Astellas Pharma Europe Ltd. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Astellas Pharma Europe Ltd. Company Profile
Astellas Pharma Europe is one of the stars in Japanese drug firm Astellas' constellation. (Astellas was formed from a merger between Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical in 2005.) Former Yamanouchi Pharma Ltd. operations in Surrey moved and merged with operations outside London later in 2005, forming Astellas Pharma Europe, which accounts for about a quarter of its parent's sales. The company sells prescription pharmaceuticals for a variety of ailments, specializing in dermatology, urology, anti-infectives, and transplantation needs. In addition to its presence in England, the division includes manufacturing plants, an R&D facility, and distribution affiliates in nearly 20 countries.
Contact Information
Address: Lovett House, Lovett Road
Staines, Surrey TW18 3AZ, England
Phone:+44-1784-4194-00
Fax:+44-1784-4194-01
Financial Highlights
Fiscal Year End:March
Revenue (2008):148.80 M
Employees (2008):100
Key People
CEO and President: Masao Yoshida
COO: Ken Jones
CFO: Seiji Kinoshita
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Major
Top Competitors
AstraZeneca PLC (azn)
Novartis AG (nvs)
Pfizer Limited
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?